Positive Outcomes of Cannabis Use Scale (POCUS)

Abstract

The Positive Outcomes of Cannabis Use Scale (POCUS) is a psychometric instrument developed by Jamie E. Parnes, Mark A. Prince, and Bradley T. Conner (2025) to measure the subjective positive consequences and perceived reinforcing benefits experienced by individuals following cannabis consumption. Historically, substance use research has operated under a deficit-oriented paradigm, prioritizing negative consequences, dependency criteria, and diagnostic classifications of cannabis use disorder. While this emphasis has informed clinical intervention and risk reduction, it has inadvertently neglected the primary driver of non-disordered and sustained consumption: perceived positive reinforcement. The POCUS addresses this critical measurement gap through a rigorous, mixed-method development pipeline following the scale construction frameworks established by Boateng et al. (2018), synthesizing deductive theoretical reviews with inductive qualitative reports from active cannabis consumers.

Comprising 19 self-report items, the POCUS evaluates four empirically established subscales: Social Enhancement, Mood Enhancement, Cognitive Enhancement, and Sexual Enhancement. The instrument implements a tripartite assessment architecture where each item is evaluated along three dimensions: behavioral event frequency (the primary scoring index, rated on a 5-point Likert scale from 1 = Never to 5 = Always/Almost Always), subjective hedonic valence (1 = Negative to 5 = Positive), and perceived motivational influence on future consumption (1 = Not at All Influential to 5 = Highly Influential). Psychometric validation across diverse samples of community-dwelling adults and university students confirmed exceptional structural validity via confirmatory factor analysis (CFA; CFI = .97, RMSEA = .040), robust internal consistency across all latent dimensions (McDonald’s ω = .85 to .87), and demonstrated incremental validity over traditional outcome expectancy measures in predicting past 30-day cannabis use frequency and concurrent negative consequences.

Keywords

Positive Outcomes of Cannabis Use Scale, POCUS, cannabis reinforcement, positive expectancies, substance use assessment, cognitive enhancement, social enhancement, mood enhancement, sexual enhancement, psychometrics, harm reduction, cannabis use disorder.

Authors

The Positive Outcomes of Cannabis Use Scale was conceptualized, psychometrically developed, and validated through an academic collaboration between clinical psychologists and behavioral health researchers:

• Jamie E. Parnes, Ph.D. — Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island, United States. Correspondence Address: 121 South Main Street, Providence, RI 02912. Email: [email protected].
• Mark A. Prince, Ph.D. — Department of Psychology, Addiction Counseling Program, Colorado State University, Fort Collins, Colorado, United States.
• Bradley T. Conner, Ph.D. — Department of Psychology, Colorado State University, Fort Collins, Colorado, United States. Author ORCID: 0000-0001-6069-4401.

Purpose

The primary purpose of the Positive Outcomes of Cannabis Use Scale (POCUS) is to provide an empirically validated, fine-grained assessment of the real-world positive outcomes, perceived functional enhancements, and subjective benefits reported by individuals who use cannabis. Over several decades, addiction science has predominantly concentrated on the pathology, physical harm, cognitive deficits, and psychosocial impairment linked to cannabis use. Assessments such as the Marijuana Adolescent Problem Inventory (MAPI) and the Rutgers Cannabis Consequences Questionnaire (R-CCQ) focus exclusively on untoward events. While indispensable for diagnosing clinical cannabis use disorder (CUD) via DSM-5 criteria, this unilateral pathology focus creates significant theoretical and empirical blind spots.

Human substance use is overwhelmingly sustained by positive and negative reinforcement mechanisms. When clinical assessments omit positive consequences, researchers and clinicians cannot fully elucidate the functional utility of cannabis from the consumer’s perspective. In clinical scenarios, understanding a patient’s perceived positive outcomes is fundamental to Motivational Interviewing (MI) and functional behavioral analyses. In MI, exploring the “pros” of cannabis use alongside the “cons” helps resolve ambivalence. If a clinician assumes a client uses cannabis merely to escape negative affect (coping/negative reinforcement), when the client actually uses it for creative focus or social ease (positive reinforcement), interventions tailored to stress reduction will likely fail to target the primary maintaining variables.

In addition to individual clinical utility, the POCUS serves an essential epidemiological and translational research function. In jurisdictions where adult-use cannabis has been legalized or decriminalized, consumer profiles have shifted markedly from clandestine recreational use to wellness-oriented, productivity-oriented, and holistic health contexts. Researchers require sensitive instruments capable of disentangling harmless or functionally beneficial consumption patterns from problematic, high-risk patterns. By capturing positive outcomes systematically across frequency, emotional valence, and behavioral influence, the POCUS allows investigators to test complex, dual-factor moderation models: determining whether individuals who experience high positive outcomes alongside high negative consequences exhibit different treatment trajectories, psychiatric comorbidities, or harm-reduction receptivity compared to those who report high negative consequences in isolation.

Psychological Construct

The construct assessed by the POCUS is the multidimensional constellation of experienced positive outcomes resulting from cannabis consumption. Unlike cognitive expectancy scales (e.g., the Marijuana Effect Expectancy Questionnaire), which measure anticipatory beliefs regarding what cannabis *might* do before ingestion, the POCUS captures actual, autobiographical experiences that occurred within a defined past-month recall window. The overarching construct operates as a hierarchical, four-dimensional framework comprising:

1. Social Enhancement

This subscale captures the facilitation of interpersonal connection, reduction of social inhibition, and perceived augmentation of communicative comfort. Social interaction often produces anticipatory anxiety or conversational friction. Cannabis is frequently consumed in shared peer settings where it serves as a social lubricant. The items within this domain measure the ease of expressing oneself openly, the willingness to initiate conversations with unfamiliar individuals, and the subjective reduction of social discomfort relative to sobriety. Representative manifestations include experiencing a heightened sense of sociability and engaging comfortably in group dynamics without self-conscious hesitation.

2. Mood Enhancement

The Mood Enhancement dimension reflects acute positive emotional transformations and the alleviation of intrusive distress. Although closely tied to emotional regulation, it encompasses both the elevation of positive emotional tone (e.g., heightened contentment, optimistic outlook) and the down-regulation of hyperarousal and physiological tension (e.g., feeling significantly calmer, experiencing fewer worries). Crucially, the POCUS construct of mood enhancement extends beyond the mere cessation of withdrawal symptoms; it captures genuine hedonic uplifts, such as an enhanced capacity to distract oneself from ruminative thoughts and an overall affective shift toward peaceful psychological equilibrium.

3. Cognitive Enhancement

The Cognitive Enhancement subscale taps into perceived gains in focus, creative problem-solving, behavioral activation, and task engagement. Cannabis is traditionally characterized in neuropsychology as an amotivational and cognitively impairing agent. However, naturalistic self-reports consistently reveal that many users perceive cannabis as a catalyst for breaking executive inertia. This construct measures the subjective facilitation of task initiation, feeling sustained energy to remain physically or intellectually active, overcoming cognitive impasses during problem-solving, and sustaining prolonged concentration on specific tasks that might otherwise induce boredom or avoidance.

4. Sexual Enhancement

The Sexual Enhancement dimension assesses perceived augmentations in intimacy, sensory pleasure, physical receptivity, and erotic intensity during sexual encounters or solitary masturbation. Cannabis interacts directly with the human endocannabinoid system, which heavily modulates neurochemical pathways governing sensory perception, tactile sensitivity, and dopamine-mediated reward circuitry. This subscale measures specific functional enhancements, including heightened sexual pleasure relative to sobriety, deepened erotic sensations, increased behavioral willingness to engage in sexual activity, and heightened gratification during sexual behavior.

Crucially, the POCUS conceptualizes these positive outcomes across three interrelated measurement facets: Occurrence Frequency (how often the outcome actually manifested in the past 30 days), Hedonic Valence (how emotionally positive or negative that manifestation was appraised), and Behavioral Influence (the extent to which that positive outcome directly drives future intention to consume). This distinction acknowledges that an outcome may occur frequently yet be appraised as neutral, or occur rarely yet serve as a major motivational driver of future drug-seeking behavior.

Theoretical Framework

The architecture of the POCUS is grounded in several converging psychological and behavioral theories that conceptualize human substance use as motivated, goal-directed behavior maintained through reinforcement learning:

1. Operant Conditioning and Reinforcement Learning

Grounded in the behavioral traditions of B.F. Skinner and contemporary neurobiological models of reinforcement, substance self-administration is fundamentally maintained by operant contingencies. Behaviors that are followed immediately by appetitive stimuli (positive reinforcement) or by the termination of aversive internal states (negative reinforcement) show an increased probability of future emission. Positive outcomes—such as sexual pleasure, conversational ease, and intellectual absorption—serve as primary and secondary reinforcers. By measuring the frequency and motivational weight of these outcomes, the POCUS operationalizes the positive reinforcement arm of operant conditioning models, complementing existing measures that strictly operationalize negative consequences (punishment or functional deficits).

2. Social Cognitive Theory and Expectancy Models

According to Albert Bandura’s Social Cognitive Theory and the substance expectancy models advanced by Goldman and colleagues, cognitive representations of drug outcomes guide decision-making. Expectancies are cognitive schemas regarding the anticipated consequences of consumption. The POCUS deepens this paradigm by transitioning from hypothetical, prospective expectancies to real-world, experienced reinforcements. Over repeated exposures, experienced outcomes consolidate into enduring cognitive expectancies, which subsequently moderate future craving and behavioral intentions.

3. Behavioral Economics and Reinforcing Efficacy

From the perspective of behavioral economics, drug choice is determined by the relative reinforcing efficacy of a substance in comparison to alternative, non-substance environmental reinforcers (e.g., employment, social relationships, exercise). If cannabis provides accessible, reliable social and mood enhancements while alternative reinforcers are scarce or costly, its reinforcing value rises disproportionately. The POCUS provides an empirical method to quantify the subjective value and perceived utility of cannabis reinforcement across specific daily domains (social, creative, erotic, emotional).

4. Khantzian’s Self-Medication Hypothesis and Functional Adaptation

Edward Khantzian’s Self-Medication Hypothesis (SMH) posits that individuals do not ingest psychoactive substances randomly; rather, they consume substances to cope with specific, unbearable emotional, psychiatric, or physical states. The POCUS expands upon the traditional view of self-medication by demonstrating that consumers do not use cannabis merely to suppress negative feelings. Instead, they actively employ cannabis as a functional tool to modulate social discomfort, overcome executive dysfunction, and cultivate hedonic well-being. This perspective aligns with harm-reduction and wellness frameworks that recognize user agency.

Validity

The psychometric validation of the Positive Outcomes of Cannabis Use Scale followed the rigorous scale-development standards articulated by Boateng et al. (2018), integrating both inductive qualitative methods and deductive statistical modeling to establish broad construct validity.

1. Content and Ecological Validity

The initial item pool was generated through a comprehensive combination of existing theoretical literature reviews and qualitative, inductive inquiry involving adult cannabis consumers. This ensured that the generated items reflected the authentic, phenomenological experiences of active consumers rather than arbitrary clinician assumptions. Refinement through cognitive debriefing and expert review resulted in a clean, face-valid 19-item battery representing distinct life domains.

2. Concurrent and Criterion Validity

The POCUS demonstrated robust concurrent validity with behavioral indices of cannabis consumption. In generalized linear modeling, total POCUS scores significantly predicted past 30-day cannabis use frequency (b = 0.48, SE = 0.05, p < .001). The calculated Incident Rate Ratio (IRR = 1.62) indicated that for every unit increase in reported positive outcomes, the expected rate of past-month cannabis use increased by 62%. This confirms that the instrument directly tracks the behavioral intensity of substance engagement.

3. Convergent Validity

Convergent validity was established by correlating the POCUS with theoretically related constructs, including established expectancy measures and adverse consequences:

• Positive cannabis effect expectancies strongly and significantly predicted POCUS scores in regression models (b = 0.48, SE = 0.04, p < .0001), displaying a bivariate correlation of r = .42. This moderate-to-strong association demonstrates that while positive expectations and experienced positive outcomes share common variance, they remain distinct constructs (anticipation vs. lived reality).
• POCUS scores also demonstrated a statistically significant positive relationship with concurrently reported negative cannabis consequences (b = 0.23, SE = 0.05, p < .001, IRR = 1.26). This finding supports dual-process models of addiction: individuals who use cannabis heavily experience higher rates of negative problems *and* report significantly more positive outcomes, rather than experiencing negative consequences in a functional vacuum.

4. Incremental Validity

To establish that the POCUS is not merely redundant with preexisting outcome expectancy or frequency metrics, hierarchical regression analyses were conducted predicting typical cannabis use frequency. The baseline model incorporating demographic factors and traditional expectancy measures explained substantial variance; however, the addition of the POCUS accounted for significantly more unique explained outcome variance (R² = .37; Δχ²(1) = 53.59, p < .001). This proves the substantial incremental validity of the POCUS over traditional measurement tools.

Reliability

The reliability of the Positive Outcomes of Cannabis Use Scale has been rigorously evaluated utilizing modern psychometric indices. While traditional behavioral science has historically relied on Cronbach’s alpha (α), methodologists widely critique alpha for its unrealistic assumption of tau-equivalence (equal factor loadings across all items) and its propensity to underestimate or artificially inflate internal consistency. Consequently, Parnes et al. (2025) evaluated internal consistency using McDonald’s Omega (ω), a superior and more robust estimate derived from structural equation modeling parameters.

Across the four empirical subscales, McDonald’s Omega coefficients confirmed high internal consistency:

• Social Enhancement Subscale: ω values ranged from .85 to .87
• Mood Enhancement Subscale: ω values ranged from .85 to .87
• Cognitive Enhancement Subscale: ω values ranged from .85 to .87
• Sexual Enhancement Subscale: ω values ranged from .85 to .87
• Overall Higher-Order Composite: ω ≥ .86

These values demonstrate that the items within each subscale share a substantial proportion of true-score variance without exhibiting problematic redundancy (which would be indicated by coefficients > .95). The standard error of measurement (SEM) across all four dimensions remained low, supporting the instrument’s clinical utility for individualized score profiling and group-level psychometric comparisons.

Factor Analysis

The dimensional structure of the POCUS was established through a two-stage analytic sequence combining initial Exploratory Factor Analysis (EFA) followed by rigorous Confirmatory Factor Analysis (CFA) across independent split samples of community adults and university students.

Exploratory Factor Analysis (EFA)

Initial item reduction and latent dimension extraction were conducted using robust maximum likelihood estimation with oblique rotation (geomin or promax), accommodating the expected inter-correlations among distinct domains of reinforcement. Iterative evaluation of eigenvalues, scree plots, and parallel analysis converged on an optimal four-factor solution. Items exhibiting poor primary factor loadings (< .40) or unacceptable cross-loadings (> .30 on secondary factors) were systematically eliminated. The final EFA yielded outstanding global fit indices:

• χ²(116) = 166.02, p < .001
• Comparative Fit Index (CFI) = .98
• Standardized Root Mean Square Residual (SRMR) = 0.02

All retained items loaded strongly onto their designated latent factors without problematic cross-loadings, demonstrating clean structural divergence across the four functional domains.

Confirmatory Factor Analysis (CFA)

The stability of the four-factor architecture was evaluated in a separate validation sample via Confirmatory Factor Analysis using the final 19-item version. The specified first-order four-factor model demonstrated exceptional goodness-of-fit to the observed data:

• χ²(171) = 2,467.87, p < .001
• Comparative Fit Index (CFI) = .97
• Root Mean Square Error of Approximation (RMSEA) = .040 (90% Confidence Interval: .030 to .050)
• Standardized Factor Loadings (λ) ranged from .61 to .86, confirming that all 19 indicators are strong, statistically significant reflections of their respective latent constructs.

Furthermore, structural equation modeling testing a higher-order factor model—in which a overarching latent construct of “Global Cannabis Positive Reinforcement” accounts for the covariance among the four first-order enhancement factors—also achieved excellent fit indices. This empirical result supports a flexible scoring approach: researchers and clinicians may validly utilize the four distinct subscale scores or aggregate them into an overarching composite score depending on the specific research question or clinical context.

Instrument / Measurement Tool

• Test Type: Original self-report psychometric rating scale.
• Item Count: 19 items organized across four subscales.
• Subscale Allocation:
  • Social Enhancement: Items 1, 6, 14, 18 (4 items)
  • Mood Enhancement: Items 3, 5, 8, 10, 15, 19 (6 items)
  • Cognitive Enhancement: Items 2, 7, 11, 13, 17 (5 items)
  • Sexual Enhancement: Items 4, 9, 12, 16 (4 items)
• Multidimensional Response Format: Each of the 19 items can be assessed using up to three distinct 5-point Likert-type response scales:
  • Scale 1: Frequency (Primary Scale) — Measures how often the event occurred in the past month:
    1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often, 5 = Always / Almost Always.
  • Scale 2: Valence (Optional Scale) — Measures the subjective emotional evaluation of the event:
    1 = Negative, 2 = Slightly Negative, 3 = Neutral, 4 = Slightly Positive, 5 = Positive.
  • Scale 3: Influence on Future Use (Optional Scale) — Measures the behavioral intention driven by the event:
    1 = Not at All Influential, 2 = Slightly Influential, 3 = Somewhat Influential, 4 = Influential, 5 = Highly Influential.
• Target Population: Adults (aged 18 years and older) who have used cannabis within the past 30 days. Validated predominantly with college students and community-dwelling adults in the United States.
• Administration Method: Self-administered electronically via online survey platforms or in-person computer terminals. Pencil-and-paper administration is also permissible.
• Scoring Procedure:
  • Primary Total Score: Calculated as the arithmetic mean of all 19 items utilizing the primary Frequency response scale (score range: 1.0 to 5.0).
  • Subscale Scores: Calculated as the arithmetic mean of the specific items composing each respective subscale (Social, Mood, Cognitive, Sexual), typically using the Frequency scale.
  • Optional Profiles: Investigators may compute separate total and subscale means for the Valence and Influence on Future Use scales to generate multidimensional motivational profiles.

Permissions & Fee and Test Year

• Year of Formal Publication: 2025.
• Copyright and Permissions: The scale was developed by Jamie E. Parnes, Mark A. Prince, and Bradley T. Conner. The authors permit non-commercial use of the POCUS for academic research, educational instruction, and non-profit clinical settings without formal licensing fees.
• Commercial Use: Any commercial use, proprietary electronic integration, or deployment within fee-for-service digital health platforms requires prior formal authorization from the primary authors.
• Contact for Permissions & Information: Inquiries should be addressed to Jamie E. Parnes, Ph.D., Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI 02912. Email: [email protected].

References

• Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Prentice-Hall.
• Boateng, G. O., Neilands, T. B., Frongillo, E. A., Melgar-Quiñonez, H. R., & Young, S. L. (2018). Best practices for developing and validating scales for health, social, and behavioral research: A primer. Frontiers in Public Health, 6, 149. https://doi.org/10.3389/fpubh.2018.00149
• Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. https://doi.org/10.3109/10673229709030550
• Parnes, J. E., Prince, M. A., & Conner, B. T. (2025). Development and initial validation of the Positive Outcomes of Cannabis Use Scale (POCUS). Psychology of Addictive Behaviors. Advance online publication.
• Skinner, B. F. (1953). Science and human behavior. Macmillan.

13. Items of the Scale (Questionnaire)